Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Kumar, Shaji ^{[1
]}

Kaufman, Jonathan L. ^{[2
]}

Mikhael, Joseph ^{[3
]}

Gasparetto, Cristina ^{[4
]}

Vij, Ravi ^{[5
]}

Pegourie, Brigitte ^{[6
]}

Benboubker, Lofti ^{[7
]}

Facon, Thierry ^{[8
]}

Moreau, Philippe ^{[9
]}

Amiot, Martine ^{[10
]}

Alzate, Stefanie ^{[11
]}

Dunbar, Martin ^{[11
]}

Xu, Tu ^{[11
]}

Agarwal, Suresh ^{[11
]}

Leverson, Joel ^{[11
]}

Ross, Jeremy ^{[11
]}

Maciag, Paulo ^{[11
]}

Verdugo, Maria ^{[11
]}

Touzeau, Cyrille ^{[12
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[3] Mayo Clin, Scottsdale, AZ USA

[4] Duke Univ, Hematol Malignancies & Cellular Therapy, Durham, NC 27706 USA

[5] Washington Univ, Sch Med, St Louis, MO 63110 USA

[6] CHU, Paris, France

[7] CHRU Hop Bretonneau, Paris, France

[8] Hop Claude Huriez, Serv Malad Sang, Lille, France

[9] Univ Hosp Hotel Dieu, Nantes, France

[10] CHU Nantes, Nantes, France

[11] AbbVie Inc, N Chicago, IL USA

[12] CHU Nantes, Nantes, France

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.clml.2017.03.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OP-045

引用

页码：E27 / E27

页数：1

共 50 条

[1] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
Kumar, S.
Kaufman, J. L.
Mikhael, J.
Gasparetto, C.
Vij, R.
Pegourie, B.
Benboubker, L.
Facon, T.
Moreau, P.
Amiot, M.
Alzate, S.
Dunbar, M.
Xu, T.
Agarwal, S.
Leverson, J.
Ross, J.
Maciag, P.
Verdugo, M.
Touzeau, C.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 100 - 101
[2] VENETOCLAX AS TARGETED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
Kumar, S.
Kaufman, J. L.
Mikhael, J.
Gasparetto, C.
Vij, R.
Pegourie, B.
Benboubker, L.
Facon, T.
Moreau, P.
Amiot, M.
Alzate, S.
Dunbar, M.
Xu, T.
Agarwal, S.
Leverson, J.
Ross, J.
Maciag, P.
Verdugo, M.
Touzeau, C.
HAEMATOLOGICA, 2017, 102 : 268 - 269
[3] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
Steinhardt, M.
Truger, M.
Bittrich, M.
Zhou, X.
Noderer, J.
Riedhammer, C.
Xiao, X.
Gawlas, S.
Philipp, W.
Eisele, F.
Haferlach, C.
Mersi, J.
Waldschmidt, J.
Einsele, H.
Rasche, L.
Kortuem, K. M.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
[4] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
Steinhardt, Maximilian J.
Truger, Marietta
Bittrich, Max
Zhou, Xiang
Noderer, Julia
Riedhammer, Christine
Xiao, Xianghui
Gawlas, Sophia
Weis, Philipp
Eisele, Florian
Haferlach, Claudia
Mersi, Julia
Waldschmidt, Johannes
Einsele, Hermann
Rasche, Leo
Kortuem, K. Martin
HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
[5] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Kumar, Shaji
Kaufman, Jonathan L.
Gasparetto, Cristina
Mikhael, Joseph
Vij, Ravi
Pegourie, Brigitte
Benboubker, Lofti
Facon, Thierry
Amiot, Martine
Moreau, Philippe
Punnoose, Elizabeth A.
Alzate, Stefanie
Dunbar, Martin
Xu, Tu
Agarwal, Suresh K.
Enschede, Sari Heitner
Leverson, Joel D.
Ross, Jeremy A.
Maciag, Paulo C.
Verdugo, Maria
Touzeau, Cyrille
BLOOD, 2017, 130 (22) : 2401 - 2409
[6] Venetoclax Monotherapy and Combined with Dexamethasone as Targeted Therapy for Relapsed/Refractory t(11;14) Multiple Myeloma
Kaufman, J.
Gasparetto, C.
Mikhael, J.
Moreau, P.
Touzeau, C.
Vij, R.
Facon, T.
Pegourie, B.
Benboubker, L.
Boise, L.
Hong, W. J.
Jiang, Y.
Alzate, S.
Dunbar, M.
Pesko, J.
Friese, K.
Ross, J.
Maciag, P.
Kumar, S.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 182 - 183
[7] Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
Ehsan, Hamid
Wahab, Ahsan
Shah, Zunairah
Sana, Muhammad Khawar
Masood, Adeel
Rafae, Abdul
Hashmi, Hamza
JOURNAL OF HEMATOLOGY, 2021, 10 (03) : 89 - 97
[8] Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma
Boccon-Gibod, Clementine
Talbot, Alexis
Le Bras, Fabien
Frenzel, Laurent
Royer, Bruno
Harel, Stephanie
Lombion, Naelle
Belhadj, Karim
Cuccuini, Wendy
Arnulf, Bertrand
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : E73 - E76
[9] Therapy of relapsed and relapsed refractory multiple myeloma
Driessen, C.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
[10] Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma
Kaufman, Jonathan L.
Gasparetto, Cristina J.
Mikhael, Joseph
Moreau, Philippe
Touzeau, Cyrille
Vij, Ravi
Facon, Thierry
Pegourie, Brigitte
Benboubker, Lofti
Boise, Lawrence H.
Alzate, Stefanie
Dunbar, Martin
Jia, Jia
Freise, Kevin J.
Verdugo, Maria
Ross, Jeremy
Maciag, Paulo
Kumar, Shaji K.
BLOOD, 2017, 130

← 1 2 3 4 5 →